Clinical Trials Logo

Clinical Trial Summary

Our study aims to investigate the effect of bacterial overgrowth induced by long-term PPI use on zonulin levels.


Clinical Trial Description

The study included a total of 75 participants, with 45 individuals classified as long-term PPI users and 30 as non-PPI users. The PPI user group was defined as those who had been consistently using PPIs (specifically omeprazole, lansoprazole, pantoprazole, esomeprazole, or rabeprazole) on a daily basis for a minimum of 6 months or at least twice a week for a minimum of 2 years. The control group comprised individuals who had never used PPIs. Venous blood samples were taken from all participants to measure serum zonulin levels. ;


Study Design


Related Conditions & MeSH terms

  • Proton Pump Inhibitor Adverse Reaction

NCT number NCT06268834
Study type Interventional
Source Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Contact
Status Completed
Phase N/A
Start date October 4, 2023
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT06384443 - Proton Pump Inhibitors in Cirrhotic Patients
Recruiting NCT05484128 - Lactobacillus Reuteri Strain Combination in Children Treated With PPI N/A
Completed NCT04426994 - Hypomagnesemia Associated With Proton-Pump Inhibitor Use
Completed NCT05815550 - Delirium Related to Proton Pump Inhibitors Use